Ajanta Pharma Ltd. | Large-cap | Healthcare
₹2,568.40
-0.65%
| Ajanta Pharma Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 46.5B
Gross Profit 35.8B 76.96%
Operating Income 23.4B 50.42%
Net Income 9.2B 19.80%
EPS (Diluted) ₹73.53

Balance Sheet Metrics

Total Assets 50.1B
Total Liabilities 12.2B
Shareholders Equity 37.9B
Debt to Equity 0.32

Cash Flow Metrics

Operating Cash Flow 12.0B
Free Cash Flow 8.4B

Revenue & Profitability Trend

Ajanta Pharma Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 46.5B 41.6B 37.1B 32.8B 28.5B
Cost of Goods Sold 10.7B 11.2B 11.2B 8.9B 6.8B
Gross Profit 35.8B 30.5B 25.9B 24.0B 21.6B
Operating Expenses 0 10.0B 10.2B 8.5B 6.4B
Operating Income 23.4B 10.5B 6.8B 8.1B 8.9B
Pre-tax Income 11.9B 11.1B 7.5B 9.1B 9.0B
Income Tax 2.7B 3.0B 1.6B 2.0B 2.5B
Net Income 9.2B 8.2B 5.9B 7.1B 6.5B
EPS (Diluted) ₹73.53 ₹64.77 ₹45.89 ₹54.96 ₹50.06

Income Statement Trend

Ajanta Pharma Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 28.4B 27.3B 28.3B 22.6B 20.3B
Non-Current Assets 21.7B 19.1B 18.5B 17.9B 17.5B
Total Assets 50.1B 46.4B 46.8B 40.6B 37.8B
Liabilities
Current Liabilities 10.0B 9.0B 11.4B 6.5B 6.5B
Non-Current Liabilities 2.3B 1.8B 1.5B 1.4B 1.3B
Total Liabilities 12.2B 10.7B 12.9B 7.9B 7.8B
Equity
Total Shareholders Equity 37.9B 35.7B 33.9B 32.6B 30.0B

Balance Sheet Composition

Ajanta Pharma Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 11.9B 11.1B 7.5B 9.1B 9.0B
Operating Cash Flow 12.0B 9.7B 7.2B 7.7B 6.9B
Investing Activities
Capital Expenditures 11.4M 133.8M 7.3M 183.8M 17.1M
Investing Cash Flow -586.0M 2.2B -3.9B 747.4M -1.1B
Financing Activities
Dividends Paid -3.5B -6.4B -896.9M -822.1M -829.0M
Financing Cash Flow -7.0B -10.3B -927.3M -4.4B -2.5B
Free Cash Flow 8.4B 6.3B 6.2B 4.1B 4.0B

Cash Flow Trend

Ajanta Pharma Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 34.90
Forward P/E 25.84
Price to Book 8.50
Price to Sales 6.89
PEG Ratio 25.84

Profitability Ratios

Profit Margin 19.80%
Operating Margin 21.92%
Return on Equity 25.02%
Return on Assets 14.61%

Financial Health

Current Ratio 2.85
Debt to Equity 1.34
Beta 0.24

Per Share Data

EPS (TTM) ₹73.50
Book Value per Share ₹301.59
Revenue per Share ₹371.47

Financial data is updated regularly. All figures are in the company's reporting currency.